Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Vor Biopharma Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 49 | 48 | −1 |
| Shares | 31.2M | 31.5M | +386.6K (+1.2%) |
| Value | $154.8M | $125.5M | −$29.3M (−18.9%) |
New holders (8)
Institutions that held Vor Biopharma Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 255,162 | $1.02M | 0.67% |
| Ensign Peak Advisors, Inc | 209,500 | $834.0K | 0.00% |
| Dimensional Fund Advisors LP | 32,945 | $131.0K | 0.00% |
| Two Sigma Investments, LP | 14,606 | $58.0K | 0.00% |
| Jane Street Group, LLC | 10,412 | $41.0K | 0.00% |
| Simplex Trading, LLC | 3,433 | $13.0K | 0.00% |
| Royal Bank of Canada | 1,572 | $6.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 356 | $1.00K | 0.00% |
Sold out (9)
Institutions that held Vor Biopharma Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 53,074 | $264.0K |
| Delphia (USA) Inc. | 16,132 | $80.0K |
| Corton Capital Inc. | 14,856 | $74.0K |
| Virtu Financial LLC | 12,252 | $61.0K |
| State of Wisconsin Investment Board | 10,800 | $54.0K |
| UBS Group AG | 865 | $4.00K |
| New York State Common Retirement Fund | 190 | $1.00K |
| Credit Suisse AG | 10 | $0 |
| Ellevest, Inc. | 46 | $0 |